Board of Directors

The Axela board deploys a broad level of domain expertise in the company’s current and targeted markets. They will strategically guide Axela as it evolves into a fully integrated and personalized medicine company.

Michael Treble (Chair)
Former President
Ibis Therapeutics

Derrick Ho
Director
Covington Capital Corporation

T. Forcht Dagi, MD
General Partner
HLM Venture Partners

 

David T. Giddings

Dave Lemus
VP Finance
Sigma-Tau Pharma

Joanne E. Harack (Corporate Secretary)